ILLUSTRATION. Health facilities owned by PT Bundamedik Tbk (BMHS). On the first day (6/7) BMHS shares immediately stuck at the upper limit of auto rejection (ARA). DOK/BMHS
Reporter: So Gumilar | Editor: So Gumilar
KONTAN.CO.ID – JAKARTA. Investors’ interest in the shares of PT Bundamedik Tbk (BMHS) is apparently very high. This can be seen at least from the performance of BMHS shares on the first day of listing on the Indonesia Stock Exchange (IDX).
When stock trading opened this morning, Tuesday (6/7) in just a matter of minutes, BMHS shares immediately stuck at the upper limit auto rejection (NOW).
Bundamedik, a hospital issuer that also manages the IVF business, sold its initial shares at Rp 340 per share and currently the price has flown 24.71% to Rp 424 per share.
The high interest of market participants in Bundamedik’s shares can also be seen from the large queues to buy in the market order book BMHS this morning.
In just about 20 minutes, the number of buying queues at the price fraction of Rp 424 per share, has reached more than 1.17 billion shares. Over time, so far the number has also continued to grow.
Also Read: Facts about Bundamedik (BMHS) IPO, Benefit from the Covid-19 Pandemic and IVF Business
For information, in celebration initial public offering (IPO) Bundamedik released 620 million ordinary shares with a nominal value of Rp 20 per share.
The number of shares issued is equivalent to 7.26% of the paid-up capital and is fully subscribed to BMHS, after the IPO and the implementation of the bond conversion.
With an initial price of Rp 340 per share, Bundamedik obtained IPO funds of Rp 210.8 billion.
A total of Rp 157.72 billion of which was used to buy back the remaining principal of the bonds from Akasya Investments Limited.
Along with the IPO, Bundamedik also issued convertible bonds to Akasya Investments Limited.
The exercise price for the bond conversion is also pegged at the level of Rp 340 per share. So the value of the converted bonds reached Rp 143.28 billion.